OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2022
(6)
2021
(5)
2025
(2)
2017
(2)
2023
(1)
2019
(1)
2018
(1)
2015
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Air Pollutants and Breast Cancer Risk: A Parallel Analysis of Five Large US Prospective Cohorts.
Not available
S-EPMC12614024
|
biostudies-literature
Cite
Rare germline copy number variants (CNVs) and breast cancer risk.
Not available
S-EPMC8766486
|
biostudies-literature
Cite
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Not available
S-EPMC9878779
|
biostudies-literature
Cite
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
Not available
S-EPMC7884683
|
biostudies-literature
Cite
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
Not available
S-EPMC8725568
|
biostudies-literature
Cite
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Not available
S-EPMC5808456
|
biostudies-literature
Cite
Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in Diabetic Retinopathy in Protocol AA.
Not available
S-EPMC11868455
|
biostudies-literature
Cite
Association analysis identifies 65 new breast cancer risk loci.
Not available
S-EPMC5798588
|
biostudies-literature
Cite
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Not available
S-EPMC4422053
|
biostudies-literature
Cite
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
Not available
S-EPMC9389436
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets